Cannabis and mesothelioma: can cannabis help with disease and treatment side-effects?
Last week, during the International Symposium on Malignant Mesothelioma, Dr. Carol Parise presented on the topic of cannabis and mesothelioma. This is a topic of interest to many because while cannabis is already in use by many cancer patients outside… Read More »
Read MoreRECAP: 2024 International Symposium on Malignant Mesothelioma, Chicago
Last week, mesothelioma patients and their families had a unique opportunity to gather with researchers, scientists, and advocates at the International Symposium on Malignant Mesothelioma in Chicago to discuss treatment advances and other mesothelioma-specific issues like asbestos litigation. The law… Read More »
Read MoreBelluck & Fox Wins Fourth Department Appeal in a Sexual Abuse Case Against Minors
For Immediate Release: Thursday, October 10, 2024 Contact: Maja Belamaric; [email protected] New York – Belluck & Fox LLP, a nationally recognized personal injury law firm, today announced that the Supreme Court of New York’s Appellate Division, Fourth Department issued a… Read More »
Read MoreBelluck & Fox Attorneys Recognized by Super Lawyers® for 15th Consecutive Year
The lawyer-rating service, Super Lawyers ®, recognized Belluck & Fox attorneys for attaining a high-degree of peer recognition and professional achievement. Joe Belluck and Jordan Fox, founding partners of Belluck & Fox, LLP, obtained this recognition for the 15th consecutive… Read More »
Read MoreNEW RECALL: Dynacare Baby Powder
The Dynarex Corporation has recalled 62 cases of its Dynacare Baby Powder due to concerns of an asbestos contamination. Individuals who purchased Dynacare Baby Powder (item number 4875) marked with Batch Number B 051 with an expiration date of 2026/12/28,… Read More »
Read MoreBelluck & Fox Sponsors Mesothelioma Patient Conference in October
The law firm of Belluck & Fox is a top sponsor of the Mesothelioma Applied Research Foundation’s annual conference which will take place on October 17-18, 2024, in Chicago. The firm’s partner, Joe Belluck, Esq., will be a speaker on… Read More »
Read MoreFirst ever FDA-approval of immunotherapy plus chemotherapy combination for advanced mesothelioma
Today, the U.S. Food and Drug Administration (FDA) approved the third ever treatment for mesothelioma. As of today, in addition to the standard chemotherapy regimen and the immunotherapy regimen, the combination of immunotherapy plus standard chemotherapy is available to clinicians… Read More »
Read MoreJoe Belluck, Jordan Fox, Seth Dymond, and Bryan Belasky Named Best Lawyers in America
For Immediate Release: August 17, 2024 Contact: David Belsky; [email protected] New York, NY – Belluck & Fox LLP is proud to announce that all four partners of the New York-based law firm have been recognized amongst the nation’s top attorneys,… Read More »
Read MoreAppellate Court Upholds Verdict and Damages in Asbestos Exposure Case
In a recent decision, the New York Appellate Division, Fourth Department unanimously affirmed a verdict obtained by a Belluck & Fox client against defendant Hedman Resources Limited, a company that mined a mineral fiber containing significant quantities of asbestos. The… Read More »
Read MoreJoseph W. Belluck Reappointed Chair of New York State Commission on Judicial Conduct
Belluck & Fox Managing Partner Joseph Belluck has been reappointed as chair of the New York State Commission on Judicial Conduct by Governor Kathy Hochul. The appointment of Belluck marks the start of a new four-year term, beginning on April… Read More »
Read More